NASDAQ:MCRB

Seres Therapeutics Stock News

etoro logo Buy MCRB
*Your capital is at risk
$4.83
+0.0500 (+1.05%)
At Close: Jul 31, 2026
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it will host an investor webcast to discuss the planned co

Seres Gets Closer To Good Times

11:34am, Thursday, 10'th Nov 2022
After accepting the BLA for SER-109, the FDA has not announced the need for an expert advisory committee. The FDA provides a firm date (April 26, 2023) for its decision concerning approval of SER-109.
Seres Therapeutics, Inc. (NASDAQ:MCRB ) Q3 2022 Earnings Conference Call November 2, 2022 8:30 AM ET Company Participants Carlo Tanzi - Head of Investor Relations Eric Shaff - President & Chief Execut
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) surged 61.4% to close at $0.92 after jumping 15% on Thursday. Nuva
U.S. stock futures traded lower this morning after recording gains in the previous session. Here are some big stocks moving lower in today’s pre-market trading session. Pagaya Technologies Ltd. (NA
Gainers BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) rose 58.2% to $8.70 in pre-market trading. BYND Cannasoft shares jumped over 32% on Monday after the company announced it has signed a share pur
Gainers IMARA Inc. (NASDAQ: IMRA) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontr
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy. Quoin Phar
Glaukos Corporation (NYSE: GKOS) gained 17.3% to $56.40 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary effica

Seres Therapeutics: What The Market Is Missing

07:00am, Friday, 19'th Aug 2022
Seres Therapeutics was founded in 2010 at a time when the Human Microbiome Project was “hot”. So Seres was there when microbiomics began to get serious. Nestle Health Science has been an early inv

Seres Therapeutics (MCRB) Reports Q2 Loss, Lags Revenue Estimates

12:15pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Seres Therapeutics (MCRB) delivered earnings and revenue surprises of -20.69% and 79.84%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Seres Therapeutics (MCRB) delivered earnings and revenue surprises of -20.69% and 79.84%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Gainers United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wedn
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE